These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12733392)

  • 1. [From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication].
    Larrey D
    Presse Med; 2003 Mar; 32(11):512-8. PubMed ID: 12733392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease.
    Weyler J; Verrijken A; Hornemann T; Vonghia L; Dirinck E; von Eckardstein A; Vanwolleghem T; Michielsen P; Peiffer F; Driessen A; Hubens G; Staels B; Francque S; Van Gaal L
    Acta Diabetol; 2021 Mar; 58(3):319-327. PubMed ID: 33084982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic morphology in obesity.
    Nasrallah SM; Wills CE; Galambos JT
    Dig Dis Sci; 1981 Apr; 26(4):325-7. PubMed ID: 7238260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric non-alcoholic fatty liver disease: an increasing public health issue.
    Berardis S; Sokal E
    Eur J Pediatr; 2014 Feb; 173(2):131-9. PubMed ID: 24068459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?
    Kazemi-Shirazi L; Veloso MP; Frommlet F; Steindl-Munda P; Wrba F; Zehetmayer S; Marsik C; Ferenci P
    Wien Klin Wochenschr; 2008; 120(1-2):25-30. PubMed ID: 18239988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
    Bosserhoff A; Hellerbrand C
    Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis in obese patients: clinical aspects and prognostic significance.
    Festi D; Colecchia A; Sacco T; Bondi M; Roda E; Marchesini G
    Obes Rev; 2004 Feb; 5(1):27-42. PubMed ID: 14969505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
    Balmer ML; Dufour JF
    Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of non-alcoholic fatty liver disease].
    Koek GH
    Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test.
    Gudowska M; Wojtowicz E; Cylwik B; Gruszewska E; Chrostek L
    Adv Clin Exp Med; 2015; 24(5):823-7. PubMed ID: 26768633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis.
    Saadeh S; Younossi ZM
    Cleve Clin J Med; 2000 Feb; 67(2):96-7, 101-4. PubMed ID: 10680276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
    Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
    J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.
    Heeks LV; Hooper AJ; Adams LA; Robbins P; Barrett PH; van Bockxmeer FM; Burnett JR
    Clin Chim Acta; 2013 Jun; 421():121-5. PubMed ID: 23694813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.
    Fierbinteanu-Braticevici C; Dina I; Petrisor A; Tribus L; Negreanu L; Carstoiu C
    World J Gastroenterol; 2010 Oct; 16(38):4784-91. PubMed ID: 20939106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-alcoholic fatty liver].
    Tagle Arrospide M
    Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.